Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Profile of Epidermolysis Bullosa Cases in King Abdulaziz Medical City, Riyadh, Saudi Arabia. | Front Genet | 2021 | 35222512 | PubTator, text mining | PubMed |
| An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases. | Front Pharmacol | 2021 | 35153741 | PubTator, text mining | PubMed |
| The Role of the Extracellular Matrix in Neural Progenitor Cell Proliferation and Cortical Folding During Human Neocortex Development. | Front Cell Neurosci | 2021 | 35140590 | PubTator, text mining | PubMed |
| Bullous diseases caused by KRT1 gene mutations: from epidermolytic hyperkeratosis to a novel variant of epidermolysis bullosa simplex. | Postepy Dermatol Alergol | 2021 | 35126011 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116493 | PubTator, text mining | PubMed |
| Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. | Front Immunol | 2021 | 35095855 | PubTator, text mining | PubMed |
| COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma. | Biomed Res Int | 2021 | 35047627 | PubTator, text mining | PubMed |
| Potential biomarkers and signaling pathways associated with the pathogenesis of primary salivary gland carcinoma: a bioinformatics study. | Genomics Inform | 2021 | 35012286 | PubTator, text mining | PubMed |
| Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure? | Int J Mol Sci | 2021 | 35008650 | PubTator, text mining | PubMed |
| Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? | Int J Mol Sci | 2021 | 35008473 | PubTator, text mining | PubMed |
| Linc01513 inhibits the malignant potential of Nasopharyngeal carcinoma by binding to PTBP1. | J Cancer | 2021 | 35003358 | PubTator, text mining | PubMed |
| Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma. | Comput Math Methods Med | 2021 | 35003322 | PubTator, text mining | PubMed |
| Autocrine Exosomal Fibulin-1 as a Target of MiR-1269b Induces Epithelial-Mesenchymal Transition in Proximal Tubule in Diabetic Nephropathy. | Front Cell Dev Biol | 2021 | 34977033 | PubTator, text mining | PubMed |
| The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity. | Front Cell Dev Biol | 2021 | 34977030 | PubTator, text mining | PubMed |
| Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells via the HCG18/miR-103a-3p/UBE2O/mTORC1/HIF-1α-Positive Feedback Loop. | Front Cell Dev Biol | 2021 | 34976998 | PubTator, text mining | PubMed |
| Molecular and Cellular Mechanisms Influenced by Postbiotics. | Int J Mol Sci | 2021 | 34948270 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. | Cancers (Basel) | 2021 | 34944923 | PubTator, text mining | PubMed |
| Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays. | Biomedicines | 2021 | 34944713 | PubTator, text mining | PubMed |
| The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34938735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=34